Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea

scientific article published on October 6, 2003

Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1026749201
P356DOI10.1186/1471-2415-3-10
P8608Fatcat IDrelease_2pgmy3wmivei3pl3g7md7ckgom
P953full work available at URLhttps://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/1471-2415-3-10
https://europepmc.org/articles/PMC239861
https://europepmc.org/articles/PMC239861?pdf=render
http://link.springer.com/content/pdf/10.1186/1471-2415-3-10.pdf
http://link.springer.com/article/10.1186/1471-2415-3-10/fulltext.html
http://link.springer.com/content/pdf/10.1186/1471-2415-3-10
P932PMC publication ID239861
P698PubMed publication ID14529574
P5875ResearchGate publication ID5558724

P2093author name stringMelinda A. Hakim
Terrence P. O'Brien
Victor E. Reviglio
Jae K. Song
P2860cites workInvestigative Ophthalmology Visual ScienceQ6060707
Matrix metalloproteinases: structures, evolution, and diversificationQ28282370
Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healingQ28573103
Matrix metalloproteinases: a reviewQ29620220
Fluoroquinolone-induced tendinopathy: what do we know?Q30716800
Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.Q31857855
Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study GroupQ35311185
Role of matrix metalloproteinases in failure to re-epithelialize after corneal injuryQ35782239
Corneal cytotoxicity of topically applied drugs, vehicles and preservativesQ36641259
Effect of topical fluoroquinolones on corneal re-epithelialization after excimer laser keratectomyQ36882014
The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use.Q43571462
In vitro susceptibilities of bacterial ocular isolates to fluoroquinolonesQ43588215
Ultrastructure of Achilles tendon from rats after treatment with fleroxacinQ43609163
Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature ratsQ44481161
The Effect of Ciprofloxacin on Tendon, Paratenon, and Capsular Fibroblast MetabolismQ56658493
Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneasQ67574658
Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicityQ67975522
Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitisQ68025416
In vitro effects of aminoglycosides and fluoroquinolones on keratocytesQ70988236
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research GroupQ71780204
Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivoQ72051046
Achilles tendinitis and tendon rupture due to fluoroquinolone antibioticsQ72124001
Deposition of topical ciprofloxacin to prevent re-epithelialization of a corneal defectQ72264124
Superinduction of cytokine gene transcription by ciprofloxacinQ72526936
Risk-benefit experience of ciprofloxacin use in pediatric patients in the United KingdomQ72993602
Ciprofloxacin causes cytoskeletal changes and detachment of human and rat chondrocytes in vitroQ73420631
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectophthalmologyQ161437
P304page(s)10
P577publication date2003-10-06
P1433published inBMC OphthalmologyQ15765692
P1476titleEffect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea
P478volume3